OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BDTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Black Diamond Therapeutics (BDTX) Earnings Date & Reports

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BDTX is expected to report earnings to rise 17.11% to -22 cents per share on November 10

Black Diamond Therapeutics BDTX Stock Earnings Reports

Q3'25

Est.

$-0.22

Q2'25

Beat

by $0.06

Q1'25

Beat

by $0.93

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.09

The last earnings report on August 07 showed earnings per share of -18 cents, beating the estimate of -24 cents. With 565.68K shares outstanding, the current market capitalization sits at 156.57M.

View a ticker or compare two or three

Compare

BDTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BDTX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BDTX showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Main Street

Phone

+1 617 252-0848

Employees

Web

https://www.blackdiamondtherapeutics.com